Terms: = Endocrine gland cancer AND FH, HLRCC, 2271, ENSG00000091483, MCUL1, MCL, LRCC, P07954 AND Treatment
131 results:
1. TCEB3 initiates ovarian cancer apoptosis by mediating ubiquitination and degradation of mcl-1.
Cai Y; Li Y; Xu Y; Yang W; Huang M
FASEB J; 2024 Apr; 38(8):e23625. PubMed ID: 38661028
[TBL] [Abstract] [Full Text] [Related]
2. What We Know about and What Is New in Primary Aldosteronism.
Ekman N; Grossman AB; Dworakowska D
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38255973
[TBL] [Abstract] [Full Text] [Related]
3. Pan-EGFR Inhibitor Dacomitinib Resensitizes Paclitaxel and Induces Apoptosis via Elevating Intracellular ROS Levels in Ovarian cancer SKOV3-TR Cells.
Lim YJ; Kim HS; Bae S; So KA; Kim TJ; Lee JH
Molecules; 2024 Jan; 29(1):. PubMed ID: 38202856
[TBL] [Abstract] [Full Text] [Related]
4. Acute mast cell leukemia without KIT D816V mutation and lack of CD2 and CD25-a case report of rare entity.
Zaremba-Pataj E; Patkowska E; Krzywdzińska A; Szumera-Ciećkiewicz A; Chlebowska-Tuz J
J Hematop; 2023 Mar; 16(1):39-47. PubMed ID: 38175371
[TBL] [Abstract] [Full Text] [Related]
5. Bcl-2 family inhibitors sensitize human cancer models to therapy.
Valentini E; Di Martile M; Brignone M; Di Caprio M; Manni I; Chiappa M; Sergio I; Chiacchiarini M; Bazzichetto C; Conciatori F; D'Aguanno S; D'Angelo C; Ragno R; Russillo M; Colotti G; Marchesi F; Bellone ML; Dal Piaz F; Felli MP; Damia G; Del Bufalo D
Cell Death Dis; 2023 Jul; 14(7):441. PubMed ID: 37460459
[TBL] [Abstract] [Full Text] [Related]
6. Metabolomics in paraganglioma: applications and perspectives from genetics to therapy.
Richter S; Garrett TJ; Bechmann N; Clifton-Bligh RJ; Ghayee HK
Endocr Relat Cancer; 2023 Jun; 30(6):. PubMed ID: 36897220
[TBL] [Abstract] [Full Text] [Related]
7. A secondary CD34+ acute lymphoblastic leukemia unmasked and mobilized by G-CSF in an autologous stem cell donor with testicular cancer.
Cooling L; Kelley J; Sexton E; Anand S; Hoffmann S
Transfusion; 2023 Apr; 63(4):684-689. PubMed ID: 36762622
[TBL] [Abstract] [Full Text] [Related]
8. Design, synthesis and biological evaluation of 2-((4-sulfamoylphenyl)amino)-pyrrolo[2,3-d]pyrimidine derivatives as CDK inhibitors.
Yang B; Quan Y; Zhao W; Ji Y; Yang X; Li J; Li Y; Liu X; Wang Y; Li Y
J Enzyme Inhib Med Chem; 2023 Dec; 38(1):2169282. PubMed ID: 36656085
[TBL] [Abstract] [Full Text] [Related]
9. The antitumor effect of the novel agent mcl/ACT001 in pancreatic ductal adenocarcinoma.
Yang J; Li Y; Han X; Pei X; Lin Z; Li C
J Cancer Res Clin Oncol; 2023 Aug; 149(9):5717-5728. PubMed ID: 36547690
[TBL] [Abstract] [Full Text] [Related]
10. Proteogenomic insights into the biology and treatment of pancreatic ductal adenocarcinoma.
Tong Y; Sun M; Chen L; Wang Y; Li Y; Li L; Zhang X; Cai Y; Qie J; Pang Y; Xu Z; Zhao J; Zhang X; Liu Y; Tian S; Qin Z; Feng J; Zhang F; Zhu J; Xu Y; Lou W; Ji Y; Zhao J; He F; Hou Y; Ding C
J Hematol Oncol; 2022 Nov; 15(1):168. PubMed ID: 36434634
[TBL] [Abstract] [Full Text] [Related]
11. A Phase II Trial of Guadecitabine in Children and Adults with SDH-Deficient GIST, Pheochromocytoma, Paraganglioma, and hlrcc-Associated Renal Cell Carcinoma.
Ligon JA; Sundby RT; Wedekind MF; Arnaldez FI; Del Rivero J; Wiener L; Srinivasan R; Spencer M; Carbonell A; Lei H; Shern J; Steinberg SM; Figg WD; Peer CJ; Zimmerman S; Moraly J; Xu X; Fox S; Chan K; Barbato MI; Andresson T; Taylor N; Pacak K; Killian JK; Dombi E; Linehan WM; Miettinen M; Piekarz R; Helman LJ; Meltzer P; Widemann B; Glod J
Clin Cancer Res; 2023 Jan; 29(2):341-348. PubMed ID: 36302175
[TBL] [Abstract] [Full Text] [Related]
12. Simultaneous inhibition of Chk1 and Bcl-xL induces apoptosis
Morimoto Y; Takada K; Takeuchi O; Watanabe K; Hirohara M; Masuda Y
J Chemother; 2023 Sep; 35(5):435-447. PubMed ID: 36134604
[TBL] [Abstract] [Full Text] [Related]
13. Inhibition of Glutamine Uptake Resensitizes Paclitaxel Resistance in SKOV3-TR Ovarian cancer Cell via mTORC1/S6K Signaling Pathway.
Kim G; Jang SK; Kim YJ; Jin HO; Bae S; Hong J; Park IC; Lee JH
Int J Mol Sci; 2022 Aug; 23(15):. PubMed ID: 35955892
[TBL] [Abstract] [Full Text] [Related]
14. Identification of immunity- and ferroptosis-related genes for predicting the prognosis of serous ovarian cancer.
Yuan X; Zhou Q; Zhang F; Zheng W; Liu H; Chen A; Tao Y
Gene; 2022 Sep; 838():146701. PubMed ID: 35777713
[TBL] [Abstract] [Full Text] [Related]
15. Aryl Hydrocarbon Receptor Promotes Cell Growth, Stemness Like Characteristics, and Metastasis in Human Ovarian cancer via Activation of PI3K/Akt, β-Catenin, and Epithelial to Mesenchymal Transition Pathways.
Therachiyil L; Krishnankutty R; Ahmad F; Mateo JM; Uddin S; Korashy HM
Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35742838
[TBL] [Abstract] [Full Text] [Related]
16. FL118, acting as a 'molecular glue degrader', binds to dephosphorylates and degrades the oncoprotein DDX5 (p68) to control c-Myc, survivin and mutant Kras against colorectal and pancreatic cancer with high efficacy.
Ling X; Wu W; Aljahdali IAM; Liao J; Santha S; Fountzilas C; Boland PM; Li F
Clin Transl Med; 2022 May; 12(5):e881. PubMed ID: 35604033
[TBL] [Abstract] [Full Text] [Related]
17. A phase II study of Navitoclax (ABT-263) as single agent in women heavily pretreated for recurrent epithelial ovarian cancer: The MONAVI - GINECO study.
Joly F; Fabbro M; Follana P; Lequesne J; Medioni J; Lesoin A; Frenel JS; Abadie-Lacourtoisie S; Floquet A; Gladieff L; You B; Gavoille C; Kalbacher E; Briand M; Brachet PE; Giffard F; Weiswald LB; Just PA; Blanc-Fournier C; Leconte A; Clarisse B; Leary A; Poulain L
Gynecol Oncol; 2022 Apr; 165(1):30-39. PubMed ID: 35123771
[TBL] [Abstract] [Full Text] [Related]
18. The Novel, Orally Bioavailable CDK9 Inhibitor Atuveciclib Sensitises Pancreatic cancer Cells to TRAIL-induced Cell Death.
Ruff JP; Kretz AL; Kornmann M; Henne-Bruns D; Lemke J; Traub B
Anticancer Res; 2021 Dec; 41(12):5973-5985. PubMed ID: 34848451
[TBL] [Abstract] [Full Text] [Related]
19. Overcoming Gemcitabine Resistance in Pancreatic cancer Using the BCL-X
Thummuri D; Khan S; Underwood PW; Zhang P; Wiegand J; Zhang X; Budamagunta V; Sobh A; Tagmount A; Loguinov A; Riner AN; Akki AS; Williamson E; Hromas R; Vulpe CD; Zheng G; Trevino JG; Zhou D
Mol Cancer Ther; 2022 Jan; 21(1):184-192. PubMed ID: 34667112
[TBL] [Abstract] [Full Text] [Related]
20. Kaempferia parviflora extract inhibits TNF-α-induced release of MCP-1 in ovarian cancer cells through the suppression of NF-κB signaling.
Thaklaewphan P; Ruttanapattanakul J; Monkaew S; Buatoom M; Sookkhee S; Nimlamool W; Potikanond S
Biomed Pharmacother; 2021 Sep; 141():111911. PubMed ID: 34328090
[TBL] [Abstract] [Full Text] [Related]
[Next]
